Paul Calabresi Career Development Award for Clinical Oncology (K12)
K12 applications for the May due date will be accepted until July 1, 2020 (NOT-CA-20-069).
The purpose of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) K12 is to increase the number of clinicians (M.D.s, D.O.s, Pharm.D.s, nurses with Ph.D.s or equivalent) trained in clinical and translational cancer research, and to promote their career development as cancer researchers.
The NCI K12 allows appointment of Scholars proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary clinical trial to an existing trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development. The PCACO is not intended to train scientists for laboratory-based research. The PCACO provides up to 5 years of support and is renewable.
For more complete information, reference the Program Announcement PAR-19-242 (K12 Clinical Trial Optional) and/or contact the program staff.
At the time of the award, the PI must be:
Established Investigators (Associate and Full Professors)
Researchers from diverse backgrounds are encouraged to participate as mentors.
At the time of the award, the scholar must be:
Clinician-scientist Scholars must be:
All non-clinical Scholars must have a:
|MD: PhD Ratio||2:1|
Scholars still in residency training must commit a minimum of 6 calendar months (50% of full-time professional effort) to research and career development. All other Scholars must commit a minimum of 9 calendar months (75% of full-time professional effort) to research and career development.
Scholars who have U.S. Veterans' Administration (VA) appointments may not consider part of the VA effort toward satisfying the "full time" requirement at the applicant institution.
|Duration of Award||2 to 4 years of support|
K12 Program Allowable Costs
|Direct Cost Limits||
All applications must not exceed $750,000 for direct costs per year.
The first year's direct costs budget is capped at $50,000. This first year is for advertising and recruitment of Scholars, Advisory Board(s) recruitment and meeting, curriculum planning and development, and development of individual Scholar's curricula.
Up to $10,000 total per annum may be allocated for all PDs/PIs of the K12 program to partially offset their salaries and associated fringe benefit costs, depending on commitment of effort.
The costs of a consultant, Program Administrator, and/or program assistant with responsibilities directly associated with the institutional career development program can be requested with justification.
|F&A Costs/Indirect Costs||8%|
Financial Support for Each K12 Fellow
|Salary||Up to $100K/year + fringe benefits|
|Research Development Support||Up to $30K/year|
How to Apply
- Applications must be submitted electronically.
- Applicants must follow the SF424 (R&R) Application Guide, as well as any program-specific instructions noted in Section IV. of the Program Announcement.
- When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions in Program Announcement.
- Applications that do not comply with these instructions may be delayed or not be accepted for review.
Application Receipt Dates and Review Schedule
Please refer to the Program Announcement for application due dates.
Applications are due by 5 pm local time.
When a standard submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.
Note: Start dates are determined by the availability of NCI funds and may not occur until well after the earliest possible start date.
Review and Selection Process
Subcommittee F convened by the Division of Extramural Activities of the NCI will determine if meets the broad needs of the program and priorities of NCI and the National Cancer Program.
For review criteria for the K12 grant mechanism, see the Section V. Application Review Criteria section of the Program Announcement.
K12 Special Notes
This is an NCI-specific Program Announcement. For all of the policies governing this award mechanism, refer to the Program Announcement.
For required Tables for New and Competing Renewal applications, please see Data tables for use with Institutional Research Training grant applications using the SF424 (R&R).
Special Institutional Statement Regarding Human Subjects Research Under K12 Support
The National Cancer Institute (NCI) Paul Calabresi Career Development Award for Clinical Oncology (K12) must be in compliance with all NIH/NCI policies pertaining to the use of human subjects. These policies apply to all research involving human subjects, not just clinical trials.
The K12 is a training and career development grant in which candidate positions are filled at the discretion of the institution, and assignment of candidate positions is generally not known at the time of application or at the time of an award. Due to this uncertainty, the word "Indefinite" should be placed in the box for IRB review date on the face page of the application, and the applicant institution must provide in the submitted grant application a Special Statement on Human Subjects Research.
NCI Staff Contacts
For additional information regarding policies and/or guidance in preparing an application for the K12 Award, contact:
- Dr. Mark Damico
- Dr. Yansong Bian
- Branch Phone: 240-276-5630
For assistance with xTrain, contact:
- Teresa Quinones-Saadipour
For technical issues with xTrain, contact the eRA Service Desk
For information regarding fiscal and/or budget issues, contact:
- Grant Management Contact
For information regarding review issues, contact:
- Referral Officer
Division of Extramural Activities